Thus, we show that ITPP is a promising agent that could prevent progression of heart failure and that its effect may go beyond simple improvement of oxygen delivery to ischaemic tissues, namely involve prevention of HIF‐1 overexpression and presumably its detrimental effects. This evidence concerns the gene HIF1A and heart failure.